Chronic Disease Control

Correlation between thyroid hormone sensitivity indices and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus

  • Qingyin WANG ,
  • Shanshan Lü ,
  • Honglin HU
Expand
  • 1.Department of Endocrinology and Metabolism,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,Anhui,China
    2.Department of Endocrinology,Fuyang Hospital of Anhui Medical University,Fuyang 236000,Anhui,China

Received date: 2026-01-16

  Online published: 2026-04-28

Abstract

Objective To investigate the associations of the thyroid feedback quantile-based index (TFQI), the thyroid-stimulating hormone index (TSHI), the thyrotropin resistance index (TT4RI), and the free triiodothyronine/free thyroxine (FT3/FT4) ratio with diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM). Methods A total of 100 patients with T2DM who were admitted to the hospital from May 2022 to May 2025 were enrolled in this study. Based on the presence or absence of DPN, these patients were divided into the DPN group (n = 43) and the non-DPN group (n = 57). Clinical data were collected, and thyroid hormone sensitivity indices were calculated. The influencing factors for DPN in T2DM were identified through univariate and multivariate logistic regression analyses. The relationship between thyroid hormone sensitivity indices and DPN was explored via Spearman correlation analysis. The predictive efficacy of these indices for DPN in T2DM was evaluated by using the receiver operating characteristic (ROC) curve. Results In comparison with the non-DPN group, the DPN group exhibited significantly lower levels of FT3, TFQI, TSHI, TT4RI, FT3/FT4, motor conduction velocity (MCV), and sensory conduction velocity (SCV). Moreover, patients in the DPN group were older (P < 0.05). Multivariate logistic regression analysis indicated that TFQI (OR = 0.491, 95%CI: 0.260 - 0.926), TSHI (OR = 0.594, 95%CI: 0.387 - 0.911), TT4RI (OR = 0.418, 95%CI: 0.183 - 0.954), and FT3/FT4 (OR = 0.540, 95%CI: 0.352 - 0.827) were independent factors influencing the occurrence of DPN in T2DM (P < 0.05). Spearman correlation analysis demonstrated that TFQI, TSHI, TT4RI, and FT3/FT4 were significantly negatively correlated with DPN (r = -0.563, -0.501, -0.541, -0.292, P < 0.05). ROC curve analysis disclosed that the area under the curve (AUC), specificity, and sensitivity of the combination of thyroid hormone sensitivity indices for predicting DPN in patients with T2DM were 0.918, 90.70%, and 93.00%, respectively. The AUC and sensitivity were significantly higher than those of TFQI, TSHI, TT4RI, or FT3/FT4 when used alone (P < 0.05). Conclusions In patients with T2DM, a decreased sensitivity to thyroid hormone indices is closely related to the occurrence of DPN, and these indices are independent influencing factors for DPN. The combined detection of these indices can improve the predictive efficacy for DPN.

Cite this article

Qingyin WANG , Shanshan Lü , Honglin HU . Correlation between thyroid hormone sensitivity indices and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus[J]. The Journal of Practical Medicine, 2026 , 42(8) : 1373 -1378 . DOI: 10.3969/j.issn.1006-5725.2026.08.010

References

[1] PAN D, XU L, CHEN P, et al. Panax Quinquefolium Saponins enhances angiogenesis in rats with diabetes and myocardial infarction[J]. J Ethnopharmacol, 2024, 319(Pt 2): 117252. doi:10.1016/j.jep.2023.117252 .
[2] ZHANG Y, YANG Y, HUANG Q, et al. The effectiveness of lifestyle interventions for diabetes remission on patients with type 2 diabetes mellitus: A systematic review and meta-analysis[J]. Worldviews Evid Based Nurs, 2023, 20(1): 64-78. doi:10.1111/wvn.12608 .
[3] JIN H Y, KIM K W, LEE K A, et al. Association of peripheral neuropathy with dementia in type 2 diabetes: A 5-year follow-up study using the national health insurance service-national health information database[J]. Endocrine, 2025, 89(2): 456-465. doi:10.1007/s12020-025-04227-6 .
[4] MIZUKAMI H. Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy[J]. Pathol Int, 2024, 74(8): 438-453. doi:10.1111/pin.13458 .
[5] GWIZDAK P, SZLACHETA P, ?ASKAWIEC-?U?AWI?SKA D, et al. Dietary habits, nutritional knowledge, and their impact on thyroid health in women: A cross-sectional study[J]. Nutrients, 2024, 16(22): 3862. doi:10.3390/nu16223862 .
[6] DUE?AS O H ROA, VAN DER BURGH A C, ITTERMANN T, et al. Thyroid function and the risk of prediabetes and type 2 diabetes[J]. J Clin Endocrinol Metab, 2022, 107(6): 1789-1798. doi:10.1210/clinem/dgac006 .
[7] WU X, ZHAI F, CHANG A, et al. Association between sensitivity to thyroid hormone indices and osteoporosis in euthyroid patients with type 2 diabetes mellitus[J]. Ther Adv Chronic Dis, 2023, 14: 20406223231189230. doi:10.1177/20406223231189230 .
[8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)(上)[J]. 中国实用内科杂志, 2021, 41(8): 668-695. doi:10.19538/j.nk2021080106 .
[9] 周甜. 心电图相关指标与2型糖尿病患者心外膜脂肪厚度及胰岛素抵抗的相关性研究[D]. 西安: 西安医学院, 2023. doi:10.7666/D03251034 .
[10] ZHU J, HU Z, LUO Y, et al. Diabetic peripheral neuropathy: Pathogenetic mechanisms and treatment[J]. Front Endocrinol, 2024, 14: 1265372. doi:10.3389/fendo.2023.1265372 .
[11] 蔡琼, 徐文晓, 吴超, 等. 腓浅神经感觉传导新方法建立及其在糖尿病周围神经病中的应用[J]. 中国神经精神疾病杂志, 2023, 49(4): 205-210. doi:10.3969/j.issn.1002-0152.2023.04.003 .
[12] 高霞, 胡延晋, 姚志, 等. 新诊断的2型糖尿病患者血管内皮功能与甲状腺激素敏感性相关性的研究[J]. 首都医科大学学报, 2024, 45(3): 413-419. doi:10.3969/j.issn.1006-7795.2024.03.007 .
[13] JIANG L, ZHOU L, LIU J, et al. Sex differences in the association between thyroid hormone sensitivity and cardiovascular-kidney-metabolic syndrome[J]. J Clin Endocrinol Metab, 2025, 110(10): e3303-e3312. doi:10.1210/clinem/dgaf059 .
[14] HE X, GAO R, WU Y, et al. Low FT3/FT4 ratio is linked to poor prognosis of acute myocardial infarction in euthyroid patients with type 2 diabetes mellitus[J]. J Clin Med, 2022, 11(21): 6530. doi:10.3390/jcm11216530 .
[15] 张有友, 贾蕊蕊, 陈栋, 等. 甲状腺功能正常中青年患者甲状腺激素及其敏感性指标与缺血性脑卒中风险的关联研究[J]. 西安交通大学学报(医学版), 2023, 44(6): 938-943. doi:10.7652/jdyxb202306015 .
[16] 胡曼玲, 苗鑫蕾, 王倩倩, 等. 甲状腺功能正常人群中甲状腺激素敏感性指数与代谢相关脂肪性肝病的相关性分析[J]. 中华内分泌代谢杂志, 2025, 41(9): 747-754. doi:10.3760/cma.j.cn311282-20241023-00487 .
[17] 周泳雯, 严晋华, 郑雪瑛, 等. 成年1型糖尿病合并自身免疫性甲状腺疾病的患病情况及糖脂代谢差异[J]. 中华糖尿病杂志, 2020, 12(8): 600-605. doi:10.3760/cma.j.cn115791-20191023-00383 .
[18] 廖慧敏, 刘秋君, 毛楚茵, 等. 2型糖尿病患者甲状腺激素中枢敏感性与缺血性心血管疾病风险相关性的研究[J]. 中国糖尿病杂志, 2023, 31(9): 657-663. doi:10.3969/j.issn.1006-6187.2023.09.002 .
[19] YU L, LIU Y, WANG Y, et al. Increased thyroid hormone sensitivity is correlated with visceral obesity in patients with type 2 diabetes[J]. Lipids Health Dis, 2024, 23(1): 337. doi:10.1186/s12944-024-02320-9 .
[20] CHAUHAN A, PATEL S S. Thyroid hormone and diabetes mellitus interplay: Making management of comorbid disorders complicated[J]. Horm Metab Res, 2024, 56(12): 845-858. doi:10.1055/a-2374-8756 .
[21] XU T, HAN T, ZHAI J, et al. Association between thyroid hormone sensitivity and non-alcoholic fatty liver disease in individuals with normal thyroid function[J]. Diabetes Metab Syndr Obes, 2025, 18: 3575-3588. doi:10.2147/DMSO.S538911 .
[22] YANG J, DING W, WANG H, et al. Association between sensitivity to thyroid hormone indices and diabetic retinopathy in euthyroid patients with type 2 diabetes mellitus[J]. Diabetes Metab Syndr Obes, 2023, 16: 535-545. doi:10.2147/DMSO.S399910 .
[23] 张有友, 贾蕊蕊, 王龙, 等. 甲状腺激素敏感性指标对甲状腺功能正常高血压患者缺血性脑卒中患病风险的影响及性别差异研究[J]. 西安交通大学学报(医学版), 2024, 45(5): 763-768. doi:10.7652/jdyxb202405010 .
[24] ZHANG J, LUO Z, ZHANG J, et al. Association between sensitivity to thyroid hormone indices and type 2 diabetic microvascular complications in euthyroid patients[J]. Sci Rep, 2024, 14(1): 31079. doi:10.1038/s41598-024-82028-z .
[25] MEHRAN L, DELBARI N, AMOUZEGAR A, et al. Reduced sensitivity to thyroid hormone is associated with diabetes and hypertension[J]. J Clin Endocrinol Metab, 2022, 107(1): 167-176. doi:10.1210/clinem/dgab646 .
[26] SUN M, YU L, ZHAO X, et al. Correlation between thyroid hormone sensitivity and diabetic peripheral neuropathy in euthyroid patients with type 2 diabetes mellitus[J]. Sci Rep, 2024, 14(1): 19603. doi:10.1038/s41598-024-70673-3 .
Outlines

/